Top compounds associated with response to DALRD3


Feature Type Standardized
Nominal ANOVA
mRNA LFM-A13 GDSC1000 pan-cancer AAC 0.08 0.02
mRNA VU0155056 CTRPv2 pan-cancer AAC -0.086 0.02
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC -0.082 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.02
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.02
mRNA AZD8055 GDSC1000 pan-cancer AAC 0.075 0.02
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.074 0.03
mRNA CEP-701 GDSC1000 pan-cancer AAC 0.074 0.03
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC -0.16 0.03
mRNA LY-2157299 CTRPv2 pan-cancer AAC -0.17 0.03
Download CSV